Protocolos en neuro-oftalmología pediátrica

  1. Nieves Martín-Begué 1
  2. Susana Noval Martín 4
  3. Jesús Barrio Barrio 2
  4. Marta Galdós Iztueta 3
  1. 1 Hospital Vall d'Hebron
    info

    Hospital Vall d'Hebron

    Barcelona, España

    ROR https://ror.org/03ba28x55

  2. 2 Clínica Universitaria de Navarra
    info

    Clínica Universitaria de Navarra

    Pamplona, España

    ROR https://ror.org/03phm3r45

  3. 3 Hospital de Cruces
    info

    Hospital de Cruces

    Barakaldo, España

    ROR https://ror.org/03nzegx43

  4. 4 Hospital Universitario La Paz
    info

    Hospital Universitario La Paz

    Madrid, España

    ROR https://ror.org/01s1q0w69

Mostrar afiliaciones +
Revista:
Acta estrabológica: publicación oficial de la Sociedad Española de Estrabología, Pleóptica, Ortóptica, Visión Binocular, Reeducación y Rehabilitación Visual

ISSN: 0210-4695,  1989-7278

Año de publicación: 2019

Volumen: 48

Número: 2

Páginas: 165-180

Tipo: Artículo

DIALNET GOOGLE SCHOLAR lock_openAcceso abierto editor

Otras publicaciones en: Acta estrabológica: publicación oficial de la Sociedad Española de Estrabología, Pleóptica, Ortóptica, Visión Binocular, Reeducación y Rehabilitación Visual

Referencias bibliográficas

  • Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology. 2013;81(13):1159-1165.
  • Martín Begué, N., Muñoz, S. Protocolo papiledema: actualización y manejo. Ann d’Oftalmología. 2018; 26: 348-356.
  • Suh SH, Suh DW, Benson C. The degree of anisocoria in pediatric patients with horner syndrome when compared to children without disease. J Pediatr Ophthalmol Strabismus. 2016;53(3):186-189.
  • Sueke H, Chandna A. Using apraclonidine in diagnosing Horner syndrome in children. Am J Ophthalmol. 2010;149(5):869;
  • Ben Shabat A, Ash S, Luckman J, Toledano H, Goldenberg Cohen N. Likelihood of Diagnosing Neuroblastoma in Isolated Horner Syndrome. J NeuroOphthalmology. February 2019:1
  • Alvi S, Karadaghy O, Manalang M, Weatherly R. Clinical manifestations of neuroblastoma with head and neck involvement in children. Int J Pediatr Otorhinolaryngol. 2017;97:157-162.
  • Vik TA, Pfluger T, Kadota R. (123)I-mIBG scintigraphy in patients with known or suspected neuroblastoma: Results from a prospective multicenter trial. Pediatr Blood Cancer. 2009;52(7):784-790.
  • Karaconji T, Whist E, Jamieson R V., Flaherty MP, Grigg JRB. Neurofibromatosis type 1: Review and update on emerging therapies. Asia-Pacific J Ophthalmol. 2019;8(1):62-72.
  • Peltonen S, Kallionpää RA, Rantanen M. Pediatric malignancies in neurofibromatosis type 1: A population-based cohort study. Int J Cancer. 2019;00:1-8.
  • Kinori M, Hodgson N, Zeid JL. Ophthalmic manifestations in neurofibromatosis type 1. Surv Ophthalmol. 2018;63(4):518-533.
  • Viola F, Villani E, Natacci F. Choroidal Abnormalities Detected by Near-Infrared Reflectance Imaging as a New Diagnostic Criterion for Neurofibromatosis 1. Ophthalmology. 2012;119(2):369-375.
  • Avery RA, Katowitz JA, Fisher MJ. Orbital/Periorbital Plexiform Neurofibromas in Children with Neurofibromatosis Type 1. Ophthalmology. 2017;124(1):123-132.
  • Anastasaki C, Morris SM, Gao F, Gutmann DH. Children with 5′-end NF1 gene mutations are more likely to have glioma. Neurol Genet. 2017;3(5):e192.
  • Anastasaki C, Gao F, Gutmann DH. Commentary: Identification of mutation regions on NF1 responsible for high- And low-risk development of optic pathway glioma in neurofibromatosis type I. Front Genet. 2019;10(MAR):1-4.
  • Parrozzani R, Miglionico G, Leonardi F. Correlation of peripapillary retinal nerve fibre layer thickness with visual acuity in paediatric patients affected by optic pathway glioma. Acta Ophthalmol. 2018;96(8):e1004-e1009.
  • Banwell B, Kennedy J, Sadovnick D. Incidence of acquired demyelina- tion of the CNS in Canadian children. Neurology. 2009; 72: 232-239.
  • Rodriguez M, Siva A, Cross SA. Optic neuritis: a population-based study in Olmsted County, Minnesota. Neurology. 1995; 45: 244-250.
  • Lehman SS1, Lavrich JB2. Pediatric optic neuritis. Curr Opin Ophthalmol. 2018; 29(5): 419-422.
  • Lock JH, Newman NJ, Biousse V, Peragallo JH. Update on pediatric optic neuritis. Curr Opin Ophthalmol. 2019.
  • Heussinger N, Kontopantelis E, Gburek-Augustat J, Jenke A, Vollrath G, Korinthenberg R, Hofstetter P, Meyer S, Brecht I, Kornek B, Herkenrath P, Schimmel M, Wenner K, Hausler M, Lutz S, Karenfort M, Blaschek A, Smitka M, Karch S, Piepkorn M, Rostasy K, Lucke T, Weber P, Trollmann R, Klepper J, Haussler M, Hofmann R, Weissert R, Merkenschlager A, Buttmann M. Oligoclonal bands predict multiple sclerosis in children with optic neuritis. Ann Neurol. 2015; 77: 1076-1082.
  • Thompson AJ, Banwell BL, Barkhof F. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018; 17: 162-173.
  • Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, de Seze J, Fujihara K, Greenberg B, Jacob A, Jarius S, Lana-Peixoto M, Levy M, Simon JH, Tenembaum S, Traboulsee AL, Waters P, Wellik KE, Weinshenker BG. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015; 85:177–189.
  • Mateo J. The Contribution of Optical Coherence Tomography in Neuromyelitis Optica Spectrum Disorders Frontiers in Neurology. 2017; 29; 8:493
  • Tekavcic Pompe M. Optic neuritis in childrenclinical and electrophysiological follow up. Doc Ophthalmol. 2003;107(3): 261-270.
  • Thompson AJ, Banwell BL, Barkhof F. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 2018; 17:162–173.
  • Beck RW, Cleary PA, Anderson MM. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group. N Engl J Med. 1992; 326:581–588.
  • Brenton JN, Banwell BL. Therapeutic approach to the management of pediatric demyelinating disease: multiple sclerosis and acute disseminated encephalomyelitis. Neurotherapeutics. 2016; 13:84-95.
Fuente de los datos: Dialnet